Who owns ACHIEVE LIFE SCIENCES INC?
- Ticker: ACHV
- CUSIP Number: 004468500
Tip: Access positions for across all investors
Analyze quarterly positions in Achieve Life Sciences with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Achieve Life Sciences stock
Who bought or sold ACHIEVE LIFE SCIENCES INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Franklin Resources | 3.9M | $14M | 0% | Dec 2024 |
|
| Propel Bio Management | 2.5M | $12M | 0% | Sep 2024 |
|
| BlackRock | 2.1M | $7.3M | 1% | Dec 2024 |
|
| Vanguard Group | 1.7M | $6.2M | -10% | Dec 2024 |
|
| Sofinnova Ventures | 1.3M | $4.6M | -14% | Dec 2024 |
|
| Geode Capital Management | 756k | $2.7M | 1% | Dec 2024 |
|
| Nantahala Capital Management | 654k | $2.3M | 0% | Dec 2024 |
|
| Shay Capital | 450k | $2.1M | 0% | Sep 2024 |
|
| State Street Corporation | 437k | $1.5M | 1% | Dec 2024 |
|
| Alyeska Investment Group | 421k | $1.5M | -11% | Dec 2024 |
|
| Northern Trust | 417k | $1.5M | 12% | Dec 2024 |
|
| Long Focus Capital Management | 248k | $1.2M | 100% | Sep 2024 |
|
| Simplify Asset Management | 218k | $1.0M | 0% | Sep 2024 |
|
| LPL Financial | 197k | $693k | 3% | Dec 2024 |
|
| Raymond James Financial | 158k | $555k | 100% | Dec 2024 |
|
| Goldman Sachs Group | 151k | $532k | -36% | Dec 2024 |
|
| Raymond James & Associates | 143k | $679k | -5% | Sep 2024 |
|
| Susquehanna International | 110k | $386k | 61% | Dec 2024 |
|
| Charles Schwab Investment Management | 90k | $315k | 0% | Dec 2024 |
|
| Bank of New York Mellon | 78k | $274k | 1% | Dec 2024 |
|
| Morgan Stanley | 76k | $268k | -16% | Dec 2024 |
|
| Wells Fargo & Company | 75k | $264k | 7% | Dec 2024 |
|
| Renaissance Technologies | 61k | $215k | 71% | Dec 2024 |
|
| Jpmorgan Chase & Co | 59k | $209k | 296% | Dec 2024 |
|
| Barclays | 54k | $189k | 12% | Dec 2024 |
|
| UBS Group | 52k | $184k | 222% | Dec 2024 |
|
| Dumac | 50k | $176k | 100% | Dec 2024 |
|
| Citigroup | 47k | $166k | 89% | Dec 2024 |
|
| Nuveen Asset Management | 47k | $164k | 0% | Dec 2024 |
|
| Pale Fire Capital SE | 41k | $146k | 25% | Dec 2024 |
|
| Rhumbline Advisers | 41k | $144k | 0% | Dec 2024 |
|
| Citadel Advisors | 36k | $128k | 39% | Dec 2024 |
|
| Bank of America Corporation | 36k | $127k | 37% | Dec 2024 |
|
| J. Goldman & Co | 25k | $86k | 0% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 23k | $79k | -2% | Dec 2024 |
|
| SG Americas Securities | 20k | $70k | 75% | Dec 2024 |
|
| Manchester Financial | 20k | $69k | 0% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 19k | $90k | 100% | Sep 2024 |
|
| Berkshire Asset Management | 18k | $53k | 0% | Dec 2024 |
|
| Squarepoint Ops | 18k | $62k | 100% | Dec 2024 |
|
| Corebridge Financial | 17k | $60k | 100% | Dec 2024 |
|
| Invesco | 17k | $59k | 4% | Dec 2024 |
|
| SBI Securities | 14k | $49k | 100% | Dec 2024 |
|
| Manufacturers Life Insurance Company | 14k | $48k | -6% | Dec 2024 |
|
| T. Rowe Price Associates | 14k | $48k | 22% | Dec 2024 |
|
| Ing Investment Management | 13k | $45k | -9% | Dec 2024 |
|
| Windsor Capital Management | 11k | $38k | 0% | Dec 2024 |
|
| Sigma Planning | 11k | $37k | 100% | Dec 2024 |
|
| Madison Park Capital Advisors | 10k | $35k | 0% | Dec 2024 |
|
| Tower Research Capital | 7.5k | $27k | 186% | Dec 2024 |
|
| Advisor Group Holdings | 7.3k | $35k | 0% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 4.9k | $17k | 100% | Dec 2024 |
|
| Royal Bank of Canada | 4.2k | $14k | 15% | Dec 2024 |
|
| Legal & General Group | 3.5k | $12k | 0% | Dec 2024 |
|
| Summit Investment Advisors | 3.4k | $12k | 0% | Dec 2024 |
|
| Stephens Consulting | 3.0k | $11k | 0% | Dec 2024 |
|
| Hanson McClain Advisors | 3.0k | $9.2k | 0% | Dec 2024 |
|
| Russell Investments | 2.9k | $10k | 43% | Dec 2024 |
|
| FMR | 2.6k | $9.1k | 25% | Dec 2024 |
|
| Brian McDonald | 2.5k | $8.8k | 0% | Dec 2024 |
|
| California State Teachers Retirement System | 2.5k | $8.8k | 0% | Dec 2024 |
|
| CWM | 2.3k | $8.0k | 997% | Dec 2024 |
|
| Amalgamated Bank | 1.2k | $4.0k | 0% | Dec 2024 |
|
| New York State Common Retirement Fund | 1.0k | $4.0k | 0% | Dec 2024 |
|
| Sterling Capital Management | 482.00 | $1.7k | 653% | Dec 2024 |
|
| Cornerstone Planning Group | 100.00 | $311.000000 | 0% | Dec 2024 |
|
| ADAR1 Capital Management | 91.00 | $431.003300 | -100% | Sep 2024 |
|
| EverSource Wealth Advisors | 26.00 | $92.001000 | 100% | Dec 2024 |
|
| IFP Advisors | 8.00 | $28.000000 | 100% | Dec 2024 |
|
Who sold out of Achieve Life Sciences?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Altium Capital Management | Jun 2024 | 216k | $1.0M |
| Caption Management | Sep 2024 | 41k | $196k |
| Verition Fund Management | Sep 2024 | 24k | $113k |
| MetLife Investment Advisors | Sep 2024 | 15k | $71k |
| Jane Street | Sep 2024 | 15k | $71k |
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | Jun 2024 | 6.4k | $30k |
| Capital Performance Advisors | Sep 2024 | 77.00 | $365.003100 |